1. Overexpression of molecular chaperons GRP78 and GRP94 in CD44^hi/CD24^lo breast cancer stem cells

Babak Nami* , Armin Ghasemi-Dizgah, Akbar Vaseghi

Bioimpacts. 2016;6(2): 105-110. doi: 10.15171/bi.2016.15

PMCID: PMC4981248 PMID: 27525228 Scopus ID: 84983485978

Article

PDF

Full Text

XML

Cited By:

Original Article

2. Introduction of a new recombinant vaccine based on GRP78 for breast cancer immunotherapy and evaluation in a mouse model

Hamed Zare , Hamid Bakherad* , Arman Nasr Esfahani, Mohamad Norouzi, Hossein Aghamollaei, Seyed Latif Mousavi Gargari, Fatemeh Mahmoodi, Mahdi Aliomrani, Walead Ebrahimizadeh

Bioimpacts. 2024;14(2): 27829. doi: 10.34172/bi.2023.27829

PMCID: PMC10945302 PMID: 38505675 Scopus ID: 85175869724

Article

PDF

XML

Cited By:

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons

1. Overexpression of molecular chaperons GRP78 and GRP94 in CD44hi/CD24lo breast cancer stem cells

2. Introduction of a new recombinant vaccine based on GRP78 for breast cancer immunotherapy and evaluation in a mouse model

1. Overexpression of molecular chaperons GRP78 and GRP94 in CD44^hi/CD24^lo breast cancer stem cells